Personal tools

MCL coexpression mm9:107

From FANTOM5_SSTAR

Revision as of 16:10, 10 October 2012 by Autoedit (talk | contribs) (Created page with "{{MCL_coexpression_mm9|gostat_on_MCL_coexpression=GO:0030318;melanocyte differentiation;0.0245230399177696;13618,20665!GO:0050931;pigment cell differentiation;0.02452303991776...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search


Phase1 CAGE Peaks

 Short description
Mm9::chr10:128241409..128241430,-p5@Tmem198b
Mm9::chr10:38684998..38685007,+p9@Lama4
Mm9::chr10:8482017..8482057,-p@chr10:8482017..8482057
-
Mm9::chr10:8482067..8482081,-p@chr10:8482067..8482081
-
Mm9::chr10:85484738..85484760,+p5@Fbxo7
Mm9::chr10:85484763..85484772,+p8@Fbxo7
Mm9::chr10:85495802..85495813,+p11@Fbxo7
Mm9::chr11:113795301..113795315,+p@chr11:113795301..113795315
+
Mm9::chr11:113927488..113927502,-p2@Sdk2
Mm9::chr11:35357986..35357997,+p6@Slit3
Mm9::chr11:35358006..35358022,+p5@Slit3
Mm9::chr11:5872449..5872475,-p@chr11:5872449..5872475
-
Mm9::chr11:5872687..5872711,-p@chr11:5872687..5872711
-
Mm9::chr12:88020400..88020411,+p@chr12:88020400..88020411
+
Mm9::chr13:115629493..115629504,+p@chr13:115629493..115629504
+
Mm9::chr13:26078079..26078090,-p@chr13:26078079..26078090
-
Mm9::chr14:104243452..104243455,-p15@Ednrb
Mm9::chr15:78986963..78986976,-p@chr15:78986963..78986976
-
Mm9::chr15:78994288..78994299,-p@chr15:78994288..78994299
-
Mm9::chr15:78994907..78994926,-p1@Sox10
Mm9::chr15:90848413..90848436,-p@chr15:90848413..90848436
-
Mm9::chr16:35853680..35853695,-p@chr16:35853680..35853695
-
Mm9::chr17:64660640..64660669,-p@chr17:64660640..64660669
-
Mm9::chr17:72942954..72942965,-p@chr17:72942954..72942965
-
Mm9::chr17:72953973..72953985,-p1@Alk
Mm9::chr18:32109348..32109364,-p4@Gpr17
Mm9::chr18:32109368..32109396,-p2@Gpr17
Mm9::chr18:32109449..32109468,-p3@Gpr17
Mm9::chr18:32109476..32109489,-p5@Gpr17
Mm9::chr18:32109524..32109538,-p6@Gpr17
Mm9::chr18:43367276..43367332,+p1@LOC100047004
p1@Stk32a
Mm9::chr18:43367333..43367354,+p2@LOC100047004
p2@Stk32a
Mm9::chr18:69752864..69752875,+p25@Tcf4
Mm9::chr18:69752912..69752928,+p9@Tcf4
Mm9::chr19:10347420..10347423,-p@chr19:10347420..10347423
-
Mm9::chr19:10379344..10379355,-p2@Dagla
Mm9::chr19:40457062..40457090,-p@chr19:40457062..40457090
-
Mm9::chr19:40457288..40457305,-p3@Sorbs1
Mm9::chr19:40457348..40457363,-p2@Sorbs1
Mm9::chr19:47538896..47538940,-p3@Sh3pxd2a
Mm9::chr19:57082677..57082713,-p1@Afap1l2
Mm9::chr1:112818931..112818935,-p@chr1:112818931..112818935
-
Mm9::chr1:112856387..112856393,-p@chr1:112856387..112856393
-
Mm9::chr1:138130615..138130628,-p@chr1:138130615..138130628
-
Mm9::chr1:138130630..138130657,-p2@5730559C18Rik
Mm9::chr1:138130690..138130711,-p4@5730559C18Rik
Mm9::chr1:168931103..168931148,+p2@Fam78b
Mm9::chr1:65358027..65358031,+p1@Pth2r
Mm9::chr1:94648758..94648763,+p@chr1:94648758..94648763
+
Mm9::chr2:125549260..125549273,-p4@Shc4
Mm9::chr2:125549393..125549427,-p1@Shc4
Mm9::chr2:125549443..125549459,-p6@Shc4
Mm9::chr2:18238569..18238603,-p@chr2:18238569..18238603
-
Mm9::chr2:58420009..58420022,-p6@Acvr1
Mm9::chr2:83564233..83564263,+p2@Itgav
Mm9::chr3:34095664..34095678,+p1@ENSMUST00000172560
Mm9::chr3:34095699..34095712,+p2@ENSMUST00000172560
Mm9::chr3:34095844..34095855,+p1@ENSMUST00000174785
Mm9::chr3:34101597..34101601,+p@chr3:34101597..34101601
+
Mm9::chr3:97841362..97841366,+p@chr3:97841362..97841366
+
Mm9::chr4:129727954..129727978,+p@chr4:129727954..129727978
+
Mm9::chr4:129727985..129727993,+p@chr4:129727985..129727993
+
Mm9::chr4:129732334..129732345,+p8@Col16a1
Mm9::chr4:129733417..129733462,+p@chr4:129733417..129733462
+
Mm9::chr4:144482577..144482586,+p16@Dhrs3
Mm9::chr4:144590339..144590345,+p@chr4:144590339..144590345
+
Mm9::chr4:98789176..98789188,-p@chr4:98789176..98789188
-
Mm9::chr4:99321776..99321807,-p1@ENSMUST00000136525
Mm9::chr4:99322678..99322679,-p@chr4:99322678..99322679
-
Mm9::chr4:99322689..99322723,-p@chr4:99322689..99322723
-
Mm9::chr4:99322726..99322731,-p@chr4:99322726..99322731
-
Mm9::chr4:99322820..99322845,+p1@Foxd3
Mm9::chr4:99322855..99322867,+p2@Foxd3
Mm9::chr4:99323046..99323073,+p3@Foxd3
Mm9::chr5:151992717..151992728,-p6@Stard13
Mm9::chr5:151992729..151992794,-p1@Stard13
Mm9::chr5:152036343..152036366,-p4@Stard13
Mm9::chr5:152036393..152036426,-p2@Stard13
Mm9::chr5:152036622..152036641,-p3@Stard13
Mm9::chr5:67490447..67490458,-p7@Phox2b
Mm9::chr5:67490474..67490494,-p2@Phox2b
Mm9::chr6:103524593..103524596,+p@chr6:103524593..103524596
+
Mm9::chr6:126711807..126711820,+p@chr6:126711807..126711820
+
Mm9::chr7:121889040..121889050,+p10@Insc
Mm9::chr7:121889188..121889197,+p9@Insc
Mm9::chr7:121889199..121889232,+p1@Insc
Mm9::chr7:121889421..121889445,+p2@Insc
Mm9::chr7:121889453..121889464,+p7@Insc
Mm9::chr7:121897212..121897227,+p12@Insc
Mm9::chr7:26033443..26033484,-p@chr7:26033443..26033484
-
Mm9::chr7:31838093..31838109,-p6@Fxyd1
Mm9::chr7:31838142..31838171,-p4@Fxyd1
Mm9::chr7:31844379..31844401,+p6@Lgi4
Mm9::chr7:31844407..31844429,+p2@Lgi4
Mm9::chr7:31844442..31844458,+p4@Lgi4
Mm9::chr7:31844566..31844654,+p1@Lgi4
Mm9::chr7:31844661..31844676,+p8@Lgi4
Mm9::chr7:31844692..31844718,+p5@Lgi4
Mm9::chr7:31845082..31845100,+p10@Lgi4
Mm9::chr7:38151719..38151721,-p@chr7:38151719..38151721
-
Mm9::chr7:38348671..38348675,-p@chr7:38348671..38348675
-
Mm9::chr7:38554436..38554440,-p@chr7:38554436..38554440
-
Mm9::chr7:38554684..38554696,-p10@Zfp536
Mm9::chr7:38555776..38555815,-p@chr7:38555776..38555815
-
Mm9::chr7:38557861..38557890,+p@chr7:38557861..38557890
+
Mm9::chr7:38557887..38557910,-p5@Zfp536
Mm9::chr7:38559002..38559009,-p15@Zfp536
Mm9::chr7:38559019..38559026,-p21@Zfp536
Mm9::chr7:56531440..56531447,+p@chr7:56531440..56531447
+
Mm9::chr8:59810908..59810928,+p1@ENSMUST00000132988
Mm9::chr8:59811222..59811252,+p@chr8:59811222..59811252
+
Mm9::chr8:95350156..95350173,+p@chr8:95350156..95350173
+
Mm9::chr9:20777404..20777418,+p@chr9:20777404..20777418
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data




Relative expression of the co-expression cluster over median <br>Analyst:



"{{{coexpression_dpi_cluster_scores_median}}}" is not a number.

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}